120 related articles for article (PubMed ID: 9378255)
1. Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice.
Ukai M; Monma J; Shinkai N; Sasaki Y; Kameyama T
Gen Pharmacol; 1997 Sep; 29(3):453-6. PubMed ID: 9378255
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors.
Ukai M; Kobayashi T; Mori K; Shinkai N; Sasaki Y; Kameyama T
Eur J Pharmacol; 1995 Dec; 287(3):245-9. PubMed ID: 8991797
[TBL] [Abstract][Full Text] [Related]
3. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
4. Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice.
Ukai M; Watanabe Y; Kameyama T
Eur J Pharmacol; 2000 May; 395(3):211-5. PubMed ID: 10812051
[TBL] [Abstract][Full Text] [Related]
5. Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, impairs memory consolidation in mice.
Ukai M; Mori K; Hashimoto S; Kobayashi T; Sasaki Y; Kameyama T
Eur J Pharmacol; 1993 Aug; 239(1-3):237-40. PubMed ID: 7901029
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
7. Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice.
Ukai M; Katoh T; Mamiya T
Neuroreport; 2001 Dec; 12(17):3723-7. PubMed ID: 11726782
[TBL] [Abstract][Full Text] [Related]
8. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit.
Niijima F; Tan-No K; Esashi A; Nakagawasai O; Tadano T; Takahashi N; Yonezawa A; Sakurada S; Kisara K
Peptides; 2000 Feb; 21(2):295-9. PubMed ID: 10764959
[TBL] [Abstract][Full Text] [Related]
10. Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice.
Ukai M; Watanabe Y; Kameyama T
Eur J Pharmacol; 2001 Jun; 421(2):115-9. PubMed ID: 11399267
[TBL] [Abstract][Full Text] [Related]
11. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
13. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
Sakaguchi M; Koseki M; Wakamatsu M; Matsumura E
Eur J Pharmacol; 2006 Jan; 530(1-2):81-7. PubMed ID: 16360145
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
16. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
17. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Hiramatsu M; Hoshino T
Brain Res; 2005 Sep; 1057(1-2):72-80. PubMed ID: 16125682
[TBL] [Abstract][Full Text] [Related]
18. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
20. Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.
Hiramatsu M; Inoue K
Eur J Pharmacol; 2000 Apr; 395(2):149-56. PubMed ID: 10794821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
